Taysha Gene Therapies(TSHA)
DALLAS, TXBiotechnology
Focus: Taysha Gene Therapies is a Dallas-based public biotech specializing in adeno-associated virus (AAV) gene therapies for rare neurological and metabolic disorders. The company is at an early clinical stage with a focused pipeline targeting high-unmet-need pediatric indications.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Taysha Gene Therapies
AI assessmentNot HiringNo open roles listed right now. Follow Taysha Gene Therapies to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$8M
Pipeline & Clinical Trials
None
Leigh SyndromeClinical Trials (1)
NCT05277363A Study of the Natural Course of SURF1 Deficiency
N/AHelp build intelligence for Taysha Gene Therapies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.